NCT00576264

Brief Summary

The purpose of this research study is to determine the genotype (genetic composition) and phenotype (physical appearance) of cells derived from the abdominal cavity to determine whether stem cells are present.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 19, 2007

Completed
4.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

June 27, 2011

Status Verified

December 1, 2007

First QC Date

December 18, 2007

Last Update Submit

June 24, 2011

Conditions

Intra-abdominal Surgery

Keywords

open abdominal surgeryabdominal laparoscopic surgeryperitoneal stem cellspatients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

subjects undergoing scheduled elective intra-abdominal surgery

You may qualify if:

  • years old
  • Male or females who are scheduled to undergo elective abdomen surgery

You may not qualify if:

  • Minors
  • Pregnant women
  • Known personal or family history of genetic disorders
  • Known history of malignancy
  • Known history of advanced liver or renal disease
  • HIV Positive: only patients who have tested negative during routine testing of their donated blood prior to surgery will be included in the study.
  • Hepatitis B and C positive
  • Scheduled to undergo lap banding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

peritoneal fluid

Study Officials

  • Prediman K Shah, MD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 18, 2007

First Posted

December 19, 2007

Study Start

April 1, 2007

Study Completion

February 1, 2012

Last Updated

June 27, 2011

Record last verified: 2007-12

Locations

US(1)